US study on incremental innovation triggers concern in India
This article was originally published in Scrip
Executive Summary
The recent launch of a study on the value of incremental pharmaceutical innovation by the US-India Business Council (USIBC) and the Coalition for Healthy India in Washington was no ordinary launch, or so it seems given the multitude of reactions the event triggered among stakeholders.